CLINICAL_TRIALS trial_result · 2014-06-02

Clinical Trial Update: Flibanserin Versus Placebo in Premenopausal Women With HSDD [Phase 3]

Phase 3 trial of Addyi (flibanserin) vs placebo in premenopausal women with hypoactive sexual desire disorder completed; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological | Phase 3 | Status: COMPLETED | Results posted: 2014-06-02